Form 4: Vor Biopharma Inc. Executive Chakraborty Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Tirtha Chakraborty, Chief Scientific Officer of Vor Biopharma Inc., sold 876 shares of common stock on August 6, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- On August 6, 2024, Tirtha Chakraborty, the Chief Scientific Officer of Vor Biopharma Inc., disposed of 876 shares of common stock.
- The transaction was executed to satisfy tax withholding obligations associated with the settlement of restricted stock units.
- The shares were sold at a price of $0.87 per share.
- Following the transaction, Chakraborty directly owns 177,372 shares of Vor Biopharma Inc.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine Form 4 filing, indicating a transaction by a company insider. Such filings are common and provide transparency into the trading activities of company executives. The sale of shares to cover tax obligations is a typical occurrence when restricted stock units vest.
Key Dates
| Date | Description |
|---|---|
| 08/06/2024 | Date of transaction: Tirtha Chakraborty disposed of 876 shares of common stock to cover tax obligations. |
| 08/08/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.